Related Experiment Videos
Preventive effect of gastrodin on cognitive decline after cardiac surgery with cardiopulmonary bypass: a
Zhao Zhang1, Pu Ma1, Younian Xu1
1Department of Anesthesiology, Huazhong University of Science and Technology, Wuhan, 430022, China.
Insights
Gastrodin significantly reduced neurocognitive decline after cardiac surgery with cardiopulmonary bypass (CPB). This study found gastrodin to be a safe and effective preventative therapy for cognitive impairment post-surgery.
Area of Science:
- Neuroscience
- Pharmacology
- Cardiology
Background:
- Cardiac surgery with cardiopulmonary bypass (CPB) frequently leads to neurocognitive decline.
- No current pharmacological treatments effectively prevent this decline.
- Gastrodin exhibits neuroprotective properties beneficial for neurological function.
Purpose of the Study:
- To investigate the efficacy of gastrodin in preventing neurocognitive decline associated with CPB.
- To evaluate gastrodin's safety profile in patients undergoing cardiac surgery.
Main Methods:
- A randomized controlled trial involving 200 patients undergoing mitral valve replacement surgery.
- Patients received either gastrodin (40 mg/kg) or a saline placebo.
- Cognitive function was assessed pre-surgery, at discharge, and at 3 months post-surgery using five neurocognitive tests.
Main Results:
- Cognitive decline occurred in 9% of the gastrodin group versus 42% in the control group at discharge (P<0.01).
- At 3 months, cognitive decline was observed in 6% of the gastrodin group compared to 31% in the control group (P<0.01).
- Adverse effects were comparable between the gastrodin and control groups.
Conclusions:
- Gastrodin is effective in preventing neurocognitive decline following mitral valve replacement surgery with CPB.
- Gastrodin demonstrates a favorable safety profile for this patient population.
- Gastrodin represents a promising therapeutic agent for mitigating cognitive impairment after cardiac surgery.
Abstract:
Cognitive decline is a common complication after cardiac surgery with cardiopulmonary bypass (CPB), but as such no pharmacological therapy has been shown to be efficacious in preventing the decline. However, gastrodin has been shown to have multi-pharmacological effects on neurological functions. We undertook this study to test the hypothesis that gastrodin would potentially prevent CPB-associated neurocognitive decline. We randomly assigned 200 patients undergoing mitral valve replacement surgery to receive either gastrodin (40 mg/kg) or saline after the induction of anesthesia and subsequently evaluated cognitive function before surgery, at discharge, and at 3rd month after surgery by using a battery of five neurocognitive tests, or adverse effects of gastrodin postoperatively. Neurocognitive decline in postoperative function was defined as a drop of 1 SD or more in the scores on tests of any one of the four domains of cognitive function. Cognitive decline occurred in 9% of the patients in the gastrodin group in contrast to 42% in the control group (P<0.01) at discharge. Cognitive outcome could be determined at 3rd month in 87 patients in the gastrodin group and 89 in the control group. Cognitive decline was detected in 6% in the gastrodin group and 31% in the control group (P<0.01). The incidences of possible adverse effects were similar between two groups. These results indicate that gastrodin is an effective and a safe drug for the prevention of neurocognitive decline in patients undergoing mitral valve replacement surgery with CPB.
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease V: Interprofessional Care
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...